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M alaria, an infectious disease that is prevalent throughout the tropics, was once readily treatable by chloroquine (CQ), a drug that was cheap, safe, and effective. CQ resistance is mediated by the Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT) (1, 2) and is associated with a marked reduction in CQ accumulation by the parasite (3, 4) . CQ is a diprotic weak base (pK a of 8.1 and 10.2, where K a is the acid dissociation constant), with the relative proportions of the neutral, mono-protonated (CQH + ), and di-protonated (CQH 2 2+ ) species varying with pH (table S1). The neutral species enters the parasite and its internal compartments via simple diffusion. When the base enters the acidic environment of the parasite's digestive vacuole [pH~5 (5) (6) (7) (8) ], the equilibrium is shifted toward the CQH 2 2+ species, which is unable to diffuse across the membrane and becomes trapped, thereby accumulating to high concentrations within this compartment. CQ is thought to exert its antimalarial effect here by interfering with the detoxification of heme, which is released as a byproduct of hemoglobin digestion.
The key resistance-conferring mutation in PfCRT is the replacement of a lysine (K) with a threonine (T) at position 76 (9) . This K76T mutation occurs in a region of the protein that is predicted to be involved in substrate recognition (10) . It is never found in isolation, but is always accompanied by a number of what are thought to be compensatory mutations in the protein (11) . We compared the function of mutant PfCRT from the CQ-resistant (CQR) P. falciparum strain Dd2 with that of wild-type PfCRT from the CQ-sensitive (CQS) strain D10 ( fig. S1 ).
The digestive vacuole is a lysosomal organelle, and the targeting of PfCRT to this compartment is likely to be mediated by discrete endosomallysosomal trafficking motifs. Upon expression of PfCRT in Xenopus oocytes, such motifs may cause the protein to be targeted to analogous organelles, rendering direct measurements of PfCRT function impractical. We therefore identified and removed multiple putative trafficking motifs from both termini of the PfCRT protein sequence ( fig. S1 ). In addition, the PfCRT coding sequence for expression in Xenopus oocytes was codonharmonized to facilitate correct folding of the protein (12, 13) . Hemagglutinin (HA)-tagged forms of this modified version of the PfCRT sequence were expressed in Xenopus oocytes, and localization of the CQS and CQR forms of PfCRT (PfCRT CQS and PfCRT CQR , respectively) to the oocyte plasma membrane was confirmed ( Fig. 1 and fig. S2 , A and B) (14) .
The successful expression of (motif-free, codon-harmonized) PfCRT at the oocyte surface enabled us to investigate the transport activity of the protein. Except where specified otherwise, uptake of [ 3 H]CQ was measured in an acidic medium (pH = 6.0), in which the majority of CQ was protonated. Oocytes expressing PfCRT CQR showed a marked (typically 5-fold, and up to 10fold) increase in [ 3 H]CQ uptake relative to noninjected controls and to oocytes expressing PfCRT CQS ( Fig. 2A ). This is consistent with PfCRT CQR , but not PfCRT CQS , mediating the transport of [ 3 H]CQ. (The membrane potential and cytosolic pH in PfCRT CQS -expressing oocytes were the same as those in PfCRT CQR -expressing oocytes; table S2.) In contrast, oocytes injected with complementary RNA (cRNA) encoding native (that is, motif-replete, nonharmonized) PfCRT CQR did not show increased [ 3 H]CQ uptake, nor was the protein present at significant levels in the plasma membrane ( fig. S3, A and B) . The sequence modifications made here therefore facilitated the functional expression of PfCRT.
T76K and S163R (15) mutations in PfCRT CQR restore CQ sensitivity to CQR parasites (9, 16) .
The introduction of either one of these changes to PfCRT CQR , each of which entailed the addition of a positive charge to the putative substratebinding site of the protein (10, 11) , resulted in the loss of CQ transport activity (Fig. 2B ). In contrast, the introduction of K76T to PfCRT CQS did not result in a significant increase in [ 3 H]CQ uptake ( Fig. 2B ). (PfCRT CQS K76T did localize to the oocyte plasma membrane; fig. S4 .) The K76T mutation is therefore necessary but not sufficient for the transport of CQ via PfCRT. This is consistent with the other PfCRT mutations acting in synergy with K76T to confer CQ resistance.
CQ transport showed a strong dependence on the pH of the medium (Fig. 2C ). Under alkaline conditions, [ 3 H]CQ was taken up to similarly high levels in noninjected oocytes and oocytes expressing PfCRT CQR or PfCRT CQS . This is likely to represent simple diffusion of uncharged CQ (uptake was nonsaturable at pH = 7.4 and 8.4; fig. S5 ). In contrast, at pH = 5.0 to 6.9, CQ transport in oocytes expressing PfCRT CQR was much higher than that in noninjected oocytes or 1 Research School of Biology, The Australian National University, Canberra, Australian Capital Territory 0200, Australia. 2 The John Curtin School of Medical Research, The Australian National University, Canberra, Australian Capital Territory 0200, Australia.
*To whom correspondence should be addressed. E-mail: rowena.martin@anu.edu.au Fig. 1 . Immunolocalization of PfCRT in the Xenopus oocyte. The oocyte plasma membrane lies over a band of granules known as the pigment layer. This, in turn, surrounds a cytoplasm crowded with yolk sacs and small endosomal-and lysosomal-type organelles (23) . Expression of C-terminally HA-tagged PfCRT CQR or PfCRT CQS results, in each case, in the appearance of a fluorescent band external to the pigment layer, indicating that both proteins are expressed in the oocyte plasma membrane. The band is not present in noninjected oocytes. Similar results were obtained with N-terminally tagged PfCRT ( fig. S2A ).
oocytes expressing PfCRT CQS [P < 0.05, analysis of variance (ANOVA)], with the maximum difference (that is, the pH optimum for PfCRT CQRmediated CQ transport) observed at pH = 6.0 ( fig. S6 ). This pH dependence is consistent with CQ being transported in its mono-or di-protonated forms. Indeed, depolarization of the membrane potential by the replacement of extracellular Na + with K + (at pH = 6.0; table S3) resulted in a 25 T 2% reduction in PfCRT CQR -mediated CQ transport ( Fig. 2D ; P < 0.005, paired t test). The decrease in PfCRT CQR -mediated CQ transport as pH was reduced from 6.9 to 5.5 (Fig. 2C ) may have been due, at least in part, to the oocyte membrane po-tential undergoing a depolarization over the same pH range (table S2) .
The uptake of [ 3 H]CQ via PfCRT CQR decreased with increasing concentrations of unlabeled CQ ( Fig. 2E ), which is consistent with a saturable transport mechanism. In contrast, raising the concentration of unlabeled CQ had little effect on [ 3 H]CQ transport in PfCRT CQS -expressing and noninjected oocytes. This is consistent with the entry of the drug into these oocytes being via simple diffusion of the neutral species. A leastsquares fit of the data to the Michaelis-Menten equation yielded an apparent Michaelis constant K M (CQ) of 245 T 3 mM and a maximum velocity V max of 67 T 13 pmol hour −1 per oocyte ( Fig. 2E , inset) for the transport of CQ via PfCRT CQR . (The presence of a high extracellular concentration of CQ did not affect the membrane potential or cytosolic pH of noninjected PfCRT CQS -or  PfCRT CQR -expressing oocytes; table S4.) Verapamil increases the accumulation of CQ by resistant parasites in vitro and thereby increases their sensitivity to CQ (4) . Verapamil inhibited the transport of CQ via PfCRT CQR ( Fig. 2F and Table 1 ; half-maximum inhibitory concentration IC 50 = 30 T 3 mM), as did a range of quinolines including quinine and amodiaquine ( to PfCRT CQS did not increase CQ transport to above that measured in oocytes expressing PfCRT CQS or in noninjected (ni) oocytes (P > 0.05, ANOVA). The introduction of T76K or S163R to PfCRT CQR resulted in the loss of PfCRT CQR -associated CQ transport ([ 3 H]CQ uptake in these oocytes did not differ significantly from that in noninjected oocytes or from oocytes expressing PfCRT CQS ; P > 0.05, ANOVA). ically effective against both CQS and CQR parasites) had no effect. Amantadine exhibits some antimalarial activity in vitro, particularly against CQR parasites (16) , and also inhibited transport via PfCRT CQR (table S5) .
Several peptides were found to cause a pronounced inhibition of CQ transport via PfCRT CQR (table S5). Most of the peptides that are active against PfCRT CQR have key elements of the CQresistance reverser pharmacophore [hydrogen bond acceptor and two hydrophobic aromatic rings (17) ] (table S6) . This pharmacophore can be viewed as defining the basic elements involved in interactions between PfCRT CQR and substrates or inhibitors.
The concentration dependence of inhibition of CQ transport was determined for a number of compounds (Table 1 and fig. S7 ). YPWF-NH 2 (endomorphin-1; an opioid receptor agonist) was the most effective peptide inhibitor of PfCRT CQRmediated CQ uptake, with an IC 50 comparable to that of quinine and verapamil. Measurements of [ 3 H]YPWF-NH 2 uptake in oocytes expressing different PfCRT constructs revealed that PfCRT CQR , but not PfCRT CQR -T76K, PfCRT CQR -S163R, or PfCRT CQS , mediates the transport of this peptide ( fig. S8 ).
We have demonstrated the transport of CQ via mutant PfCRT, which provides an explanation for the phenomenon of CQ resistance, as well as for the reversal of CQ resistance by reversing agents such as verapamil. The presence of a positive charge (K76 or R163) in the PfCRT substratebinding site prevents CQH 2 2+ (or CQH + ) from interacting with the transporter. The K76T mutation removes the positive charge, altering the substrate specificity of PfCRT to allow the transport of the protonated drug. In the parasite, the presence of mutant PfCRT on the digestive vacuole will allow the protonated drug to be transported down its electrochemical gradient, out of the vacuole, and thus away from its site of action ( fig. S9 ). This mechanism is consistent with recent studies implicating PfCRT CQR in the transport of [ 3 H]CQ in CQR parasites (18) (19) (20) and in Dictyostelium discoideum transformants expressing PfCRT at endosomal membranes (21) . It is also consistent with the recent demonstration of a (verapamil-sensitive) CQ-mediated efflux of H + from the digestive vacuole of CQR parasites (22) . The achievement of a robust expression system for PfCRT has the potential to facilitate the rational design of novel CQ-like drugs that bypass the resistance mechanism and/or the design of clinically effective resistance-reversing agents. To explore the mechanisms and evolution of cell-cycle control, we analyzed the position and conservation of large numbers of phosphorylation sites for the cyclin-dependent kinase Cdk1 in the budding yeast Saccharomyces cerevisiae. We combined specific chemical inhibition of Cdk1 with quantitative mass spectrometry to identify the positions of 547 phosphorylation sites on 308 Cdk1 substrates in vivo. Comparisons of these substrates with orthologs throughout the ascomycete lineage revealed that the position of most phosphorylation sites is not conserved in evolution; instead, clusters of sites shift position in rapidly evolving disordered regions. We propose that the regulation of protein function by phosphorylation often depends on simple nonspecific mechanisms that disrupt or enhance protein-protein interactions. The gain or loss of phosphorylation sites in rapidly evolving regions could facilitate the evolution of kinase-signaling circuits. C yclin-dependent kinases (Cdks) drive the major events of the eukaryotic celldivision cycle (1) . Comprehensive identification and analysis of Cdk substrates would enhance our understanding of cell-cycle control and provide insights into the mechanisms and evolution of regulation by phosphorylation. We therefore developed methods for comprehensive identification of the sites of Cdk1 phosphorylation on large numbers of substrates in vivo. We Table 1 . IC 50 values for the inhibition of PfCRT CQR -mediated CQ transport by a number of drugs and peptides. PfCRT CQR -mediated CQ transport was calculated by subtracting the uptake measured in oocytes expressing PfCRT CQS from that in oocytes expressing PfCRT CQR . The data are shown in fig. S7 and Fig. 2F . IC 50 values were derived by least-squares fit of the equation
where Y is PfCRT CQR -mediated CQ transport, Y min and Y max are the minimum and maximum values of Y, and C is a constant. All values are mean T SEM from n = 3 or 4 separate experiments, within which measurements were made from 10 oocytes per treatment.
Compound
IC 50 (mM) Immunofluorescence analysis. Oocytes expressing HA-tagged PfCRT were fixed and labelled with antibodies three days after injection (50 ng per oocyte) using a protocol described elsewhere (27) . Mouse anti-HA antisera and Alexa Fluor 488 goat anti-mouse antibody (Molecular Probes) were used at concentrations of 1 in 100 and 1 in 500, respectively. Oocytes were embedded in an acrylic resin as described previously (25) and slices viewed using a Leica Microsystems inverted confocal laser microscope.
Surface Biotinylation and Western blot analysis. Oocytes expressing HA-tagged PfCRT
were treated with Sulfo-NHS-Biotin (1 mg/ml; Pierce) three days after injection (50 ng per oocyte). The oocytes were then lysed, the membranes solubilized, and purified biotinylated protein prepared using streptavidin-coated agarose beads (Pierce), as described elsewhere (28) . Western blot analysis of biotinylated protein preparations was performed as described previously (29) , and membranes were probed with mouse anti-HA antisera (1:1000).
Primary antibody binding was detected using Alexa Fluor 488 goat anti-mouse antibody (1:
10,000; Molecular Probes).
Electrophysiological measurements. The intracellular pH and membrane potential of oocytes (4-6 days post-injection) was determined using simultaneous recording with two intracellular electrodes. The tip of the pH-sensitive electrode was coated with tributylchlorosilane (Fluka). Subsequently the tip was back-filled with H + -ionophore Icocktail A (Fluka) followed by a layer of 0.1M Na-citrate pH 6.0 (titrated with HCl), as described elsewhere (26) . The electrode used for measuring membrane potential contained 300 mM KCl. The electrodes were connected via a headstage (0.001X gain for pHsensitive electrode (Model H2S, Axon Instruments), 1 X gain for membrane potential (Model HS-2A 1 X LU)) to an Axoclamp 2A amplifier (Axon Instruments) or to a Geneclamp 500B amplifier (Axon instruments). The voltage outputs of the two electrodes were measured relative to an agar reference electrode. The pH electrode sensitivity (58 ± 3 mV/ pH unit) was measured at the beginning and end of each experiment. The intracellular pH was calculated using pHi = pHo − (VpH−Vm)/S, where pHo is the pH of the extracellular solution, VpH is the voltage measured by the pH electrode when the oocyte was impaled, Vm is the membrane potential, and S is the sensitivity of the electrode.
The composition of the Na + -replete and Na + -free solutions used to suspend the oocytes were identical to those used in the radio-isotope uptake assays (Na + -replete medium: 96 S1 . Putative endosomal/lysosomal trafficking motifs in the PfCRT sequence. The amino acid sequence of PfCRT from the CQ-resistant Plasmodium falciparum strain Dd2 is shown aligned with wild-type PfCRT from the CQ-sensitive strain D10 and homologues from P. chabaudi, P. berghei, P. yoelii, P. vivax, and P. knowlesi. PfCRT is predicted to contain 10 transmembrane domains (TMDs; the positions of TMDs 1 and 10 are indicated) and to be orientated with the N-and C-termini in the parasite cytosol (10) . Since the distribution of positively-charged residues (which determines the orientation of proteins in membranes; 'positive inside rule' (30, 31) ) was not altered, the transporter is likewise expected to orientate with the termini in the cytosol when expressed at the oocyte plasma membrane. Lysosomal/ endosomal targeting motifs (32, 33) are typically found in the cytosolic tails of a membrane protein and an examination of these regions of PfCRT revealed the presence of six putative motifs. Four of these -three "dileucine" motifs (Dileu) and a "tyrosine-based" motif (Tyr) -are located in the N-terminus and the remainderan "acidic cluster" and a dileucine motif -are in the C-terminus. All three types of motifs are known to be inactivated by the replacement of key residues with alanine (32-37). We therefore substituted such residues with alanine in all six of the putative motifs ("A" indicates that the residue above was replaced with alanine) in both PfCRT CQS and PfCRT CQR . The positions of the two residues (76 and 163) known to play a primary role in conferring/reversing resistance are indicated. The NCBI accession (gi) number of each protein is given. Residues are shaded as follows: positively charged, blue; negatively charged, red; hydoxyl, orange; amido, gray; proline, green; cysteine, purple; histidine, mid blue; glycine, light blue; tryptophan and tyrosine, olive green; remaining nonpolar, yellow. PfCRT CQR at intracellular membranes would only have affected CQ accumulation if the lumen of the vesicle/organelle was acidic, and even then, the direction of this effect is predicted to be the opposite of that which was observed, i.e. a decrease, not an increase, in CQ accumulation by oocytes). Addition of the HA-tag did not alter the substratespecificity of PfCRT; oocytes expressing HA-tagged PfCRT CQR accumulated [ 3 H]CQ significantly above levels in non-injected oocytes, whereas oocytes expressing tagged PfCRT CQS did not (data not shown). Similar results were obtained with C-terminally tagged PfCRT (Fig. 1). (B PfCRT CQR * sequence was not harmonized for expression in X. laevis and encodes a PfCRT CQR protein replete with all putative trafficking motifs. CQ transport in oocytes expressing PfCRT CQR * was not significantly different from that measured in non-injected oocytes or oocytes expressing PfCRT CQS (P > 0.05). By contrast, oocytes expressing the modified PfCRT CQR sequence accumulated CQ to levels significantly above that seen in non-injected oocytes or oocytes expressing PfCRT CQS or PfCRT CQR * (P < 0.001). P values were calculated using ANOVA in conjunction with Tukey's multiple comparisons test. Uptake is shown as mean ± s.e.m. from 5 separate experiments, within each of which measurements were made from 10 oocytes per treatment. (B) Immunofluorescence microscopy assay of oocytes expressing N-terminally HA-tagged PfCRT CQR *. Expression of N-terminally HA-tagged PfCRT CQR resulted in the appearance of a fluorescent band external to the pigment layer, indicating that PfCRT CQR was expressed in the oocyte plasma membrane (see also Fig. 1 and fig. S2A ). By contrast, N-terminally HA-tagged PfCRT CQR * was not expressed at significant levels in the plasma membrane. The finding here that PfCRT CQS K76T did not mediate CQ transport (Fig. 2B ) differs from that of Naude et al (21) , who reported that this protein transports CQ (albeit at a reduced capacity compared with PfCRT CQR ). In their study, Naude and colleagues expressed PfCRT CQR , PfCRT CQS and PfCRT CQS K76T at the membranes of acidic endosomes in Dictyostelium discoideum and found that PfCRT CQR -and to a lesser extent PfCRT CQS K76T -caused a verapamil-sensitive decrease in CQ accumulation in these organelles, whereas PfCRT CQS did not. However, there are key differences between our study and that of Naude et al, aside from the use of different expression systems, that may explain this discrepancy.
A B
The D. discoideum genome encodes three homologues of PfCRT, and the product of one of these genes (DdCRTp1) localizes to the acidic endosomes (38) . All of the PfCRT constructs Naude et al expressed in D. discoideum were chimeras of DdCRTp1 and PfCRT; residues 1-58 of PfCRT were replaced by residues 1-49 of DdCRTp1 to facilitate expression of the protein at the acidic endosomes. It is possible that replacement of the PfCRT N-terminus with that of DdCRTp1 altered the properties of the transporter, such that introduction of K76T to DdCRTp1-PfCRT CQS resulted in (partial) CQ transport activity. Likewise, it cannot be ruled out that the modifications we made to the termini of PfCRT (mutation of residues in six putative trafficking motifs to alanine) modified the activity of PfCRT CQS K76T.
Furthermore, given that both DdCRTp1 and DdCRTp1-PfCRT localize to the same membrane (that of the acidic endosomes) and that members of the CRT family have been postulated to function as dimers (10), it is possible that heterodimers of DdCRTp1 and DdCRTp1-PfCRT form in the D. discoideum expression system. DdCRTp1 contains serine (one of two hydroxy amino acids, the other being threonine) at the position corresponding to the K76T mutation. DdCRTp1 also possesses amino acids associated with CQ resistance at two other key positions -the residues corresponding to 220 and 356 in PfCRT (serine and threonine, respectively). Therefore, a heterodimer formed from DdCRTp1 and DdCRTp1-PfCRT CQS K76T would contain a hydroxy amino acid at position 76 in both monomers, as well as two additional resistance-associated mutations in one monomer, and it is conceivable that such a dimer may transport CQ. By contrast, heterodimers of DdCRTp1 and DdCRTp1-PfCRT CQS and homodimers of DdCRTp1-PfCRT CQS K76T, while containing a hydroxy amino acid at position 76 in one or both of the monomers respectively, would not possess any other resistance-associated mutations. These differences may be sufficient to permit CQ transport via a heterodimer of DdCRTp1 and DdCRTp1-PfCRT CQS K76T, but not via a heterodimer of DdCRTp1 and DdCRTp1-PfCRT CQS or a homodimer of DdCRTp1-PfCRT CQS K76T. Since Xenopus laevis does not encode a member of the CRT family, heterodimers between PfCRT CQS K76T (or any other PfCRT protein) and an endogenous protein are unlikely to form in the oocyte expression system. The pH-dependence of the non-saturable component of CQ uptake seen in oocytes of all types is likely to reflect the pH-dependence of the concentration of uncharged CQ present in the medium. The uncharged CQ species crosses biological membranes via simplediffusion across the lipid bilayer, and the rate at which [ 3 H]CQ enters the oocyte via this route form will be dependent upon the concentration of the uncharged species. As the pH was increased from 6.0 to 7.4 or 8.4 the concentration of uncharged CQ in the solution increased ~530-fold and >20900-fold, respectively (table S1) . Hence, as the pH was shifted from acidic to alkaline the proportion of CQ entering the oocyte via simple diffusion will have increased dramatically, resulting in the high levels of (non-saturable) CQ accumulation shown here. At the more alkaline pH values the rate of transport of protonated CQ via PfCRT CQR was relatively low compared to the rate of entry of [ 3 H]CQ via simple diffusion of the neutral species, and the level of CQ accumulation in oocytes expressing PfCRT CQR was, as a result, indistinguishable from that in control oocytes. It is also worth noting that a preference of PfCRT CQR for CQH 2 2+ over CQH + would result in reduced CQ uptake via the transporter at alkaline pH values; the level of CQH 2 2+ decreased by 66.5% when the pH was increased from 6.0 to 8.4. P values were calculated using ANOVA in conjunction with Tukey's multiple comparisons test. Uptake is shown as mean ± s.e.m. from 3 separate experiments, within each of which measurements were made from 10 oocytes per treatment.
The finding here that [ 3 H]CQ transport was cis-inhibited by unlabelled CQ in oocytes expressing PfCRT CQR (see also Fig. 2E ) is in agreement with the report by Sanchez et al (39) that [ 3 H]CQ efflux from CQR parasites is cis-inhibited by unlabelled CQ. Sanchez and colleagues have reported that when parasites are preloaded with increasing concentrations of unlabelled CQ, [ 3 H]CQ uptake in CQR parasites is stimulated (at low preloaded CQ concentrations) and then inhibited (at high preloaded CQ concentrations). Under the same conditions, preloaded CQ inhibits (and does not stimulate) CQ uptake in CQS parasites. Sanchez et al attributed the effect seen in CQR parasites to competitive inhibition of [ 3 H]CQ efflux by unlabelled CQ (i.e. cis-inhibition). That is, the preloaded unlabelled CQ competes with [ 3 H]CQ in the vacuole for efflux via PfCRT CQR , resulting in reduced movement of [ 3 H]CQ out of the vacuole and thus an increase in the accumulation of radiolabel. We have demonstrated the phenomenon of cis-inhibition of PfCRT CQRmediated [ 3 H]CQ uptake by unlabelled CQ (Fig. 2E and fig. S5) PfCRT CQR T76K 0.42 ± 0.05; and PfCRT CQR S163R 0.42 ± 0.05. There was no difference in the rate of YPWF-NH 2 uptake between PfCRT CQS -, PfCRT CQR -T76K-, PfCRT CQR -S163R-, and non-injected oocytes (P > 0.05), however the rate of peptide transport in oocytes expressing PfCRT CQR was significantly greater than that measured in all other oocytes (P < 0.001). By contrast, there was no difference in YPWF-NH 2 accumulation between the five cell types in the presence of unlabelled peptide, verapamil, or CQ (P > 0.05), indicating that the increased uptake of the peptide into oocytes expressing PfCRT CQR was saturable, and inhibited by both verapamil and CQ, consistent with YPWF-NH 2 transport being via PfCRT CQR . (B) pH-dependence of the uptake of radiolabelled Endomorphin-1 into noninjected oocytes (white bars), oocytes expressing PfCRT CQS (grey bars) and oocytes expressing PfCRT CQR (black bars). PfCRT CQR -mediated transport of Endomorphin-1 was observed at pH 6.0, 6.4, and 7.4, but not at pH 5.0 or 9.0 (the rate of YPWF-NH 2 uptake in oocytes expressing PfCRT CQR was significantly greater than that measured in PfCRT CQSand non-oocytes at pH 6.0, 6.4 and 7.4 (P < 0.05), but there was no difference between the three cell types at pH 5.0 and 9.0 (P > 0.05)). At pH 5.0 YPWF-NH 2 (a peptide in which the charge on the terminal carboxyl group is masked by an -NH 2 group) is present predominantly as a cation; the decrease in PfCRT CQR -mediated transport at pH 5.0 (relative to that at pH 6.0-7.4; P < 0.05) may be due at least in part to depolarisation of the oocyte plasma membrane, as seen with PfCRT CQR -mediated CQ transport (Fig. 2D) . P values were calculated using ANOVA in conjunction with Tukey's multiple comparisons test. Uptake is shown as mean ± s.e.m. from 6 (A) or 5 (B) separate experiments, within which measurements were made from 10 oocytes per treatment.
Fig. S9
. Model for the molecular mechanism underlying the phenomenon of CQ resistance in P. falciparum malaria. The loss of the positive charge associated with K76 alters the substrate specificity of PfCRT to allow the efflux of CQH 2 2+ (and/or CQH + ), down its electrochemical gradient, out of the digestive vacuole and away from its site of action. The K76T mutation is necessary but not sufficient for the transport of CQ via PfCRT. The efflux of CQ via PfCRT is blocked by the CQ-resistance reverser verapamil, the antiviral agent amantadine, and by a number of quinoline antimalarials (quinine, quinidine, cinchonine, cinchonidine, amodiaquine, isoquine, mefloquine, and primaquine; table S5). Neither the bisquinoline drug piperaquine (clinically effective against both CQS and CQR parasites) nor the structurally unrelated antimalarial artemisinin inhibit the transport of CQ via PfCRT. Table S2 . Cytosolic pH and membrane potential of PfCRT-expressing oocytes over the extracellular pH range 7.4-5.5. Measurements were performed on oocytes suspended in Na + -replete medium, as described in the Methods. At each of the extracellular pH values tested there was no significant difference between the cytosolic pH of PfCRT CQS -, PfCRT CQR -, and non-injected oocytes (P > 0.05). The intracellular pH of oocytes suspended at pH 7.4 was not different from that of oocytes suspended at pH 6.9 (P > 0.05).
Decreasing the extracellular pH from 7.4 to 6.0 or 5.5, or from 6.9 to 6.0 or 5.5, however, caused a small but significant acidification of the cytosol in all oocytes (P < 0.01 and P < 0.05, respectively). Oocytes expressing PfCRT CQS or PfCRT CQR were depolarized relative to non-injected oocytes at each pH (P < 0.001) but, crucially, the magnitude of depolarization was the same for both PfCRT CQS -and PfCRT CQR -expressing oocytes (P > 0.05) (NB It is not an uncommon observation that oocytes expressing foreign proteins undergo depolarization (40) (41) (42) . The cause of this phenomenon has not been elucidated, but is likely to be due, at least in part, to high expression levels of foreign protein at the oocyte surface being at the expense of expression of endogenous channels and transporters that play a role in maintaining the normal oocyte membrane potential.) Oocytes suspended at pH 6.0 or pH 5.5 were depolarized relative to oocytes at pH 7.4 (P < 0.01) and pH 6.9 (P < 0.001). In summary, PfCRT CQS -and PfCRT CQR -expressing oocytes shared the same cytosolic pH and membrane potential under conditions in which there was no difference in [ 3 H]CQ accumulation between the two cell types (pH 7.4) as well as under conditions in which PfCRT CQR -expressing oocytes accumulated [ 3 H]CQ to levels significantly higher than those measured in PfCRT CQS -expressing oocytes (pH 6.9-5.5; Fig. 2C ). The values are mean ± s.e.m. from 3 separate experiments, within which measurements were made from at least 7 oocytes per treatment. P values were calculated using ANOVA in conjunction with Tukey's multiple comparisons test. PfCRT CQR -expressing oocytes from the same batch, and on the same day of the electrophysiological measurements, accumulated [ 3 H]CQ significantly above levels in PfCRT CQS -expressing and non-injected oocytes at pH 6.0 (data not shown).
Cytosolic pH Membrane potential (mV)
Extracellular pH Non-injected PfCRT CQS PfCRT CQR Non-injected PfCRT CQS PfCRT CQR  Table S3 . Effect of extracellular [Na + ] on the cytosolic pH and membrane potential of PfCRT-expressing oocytes at pH 7.4 and 6.0. Measurements were performed on oocytes suspended in medium containing 0, 30, or 96 mM Na + , as described in the Methods. In all oocytes, and at both pH 7.4 and 6.0, decreasing the extracellular concentration of Na + from 96 to 30 or 0 mM depolarized the cell (P < 0.001) and caused a small but significant alkalisation of the cytosol (P < 0.05). N.B. This very modest change in cytosolic pH did not significantly alter the diffusion of [ 3 H]CQ into the oocyte (c.f. non-injected and PfCRT CQS -expressing oocytes in the presence and absence of 96 mM Na + ; Fig. 2D ). Under each of the conditions tested there was no significant difference between the cytosolic pH of PfCRT CQS -, PfCRT CQR -, and non-injected oocytes (P > 0.05). Similarly, at each of the conditions tested there was no significant difference between the membrane potentials of PfCRT CQS -and PfCRT CQR -expressing oocytes (P > 0.05 Table S4 . Cytosolic pH and membrane potential of PfCRT-expressing oocytes in the absence and presence of extracellular CQ at pH 6.0. Measurements were performed on oocytes suspended in Na + -replete medium containing 0, 15, or 500 µM extracellular CQ, as described in the Methods. Under each of the conditions tested there was no significant difference between the cytosolic pH of PfCRT CQS -, PfCRT CQR -, and non-injected oocytes (P > 0.05), nor any significant difference between the membrane potentials of PfCRT CQS -and PfCRT CQR -expressing oocytes (P > 0.05); i.e. CQ had no significant effect on either the cytosolic pH or membrane potential of oocytes, when present at either (i) the low concentration (15 µM) present in the [ 3 H]CQ-uptake assays (e.g. Fig. 2A ) or (ii) a high concentration (500 µM) known to inhibit [ 3 H]CQ uptake via PfCRT CQR at pH 6.0 while having no effect on the diffusion of [ 3 H]CQ into PfCRT CQS -expressing or non-injected oocytes (fig. S5) . The values are mean ± s.e.m. from 3 separate experiments, within which measurements were made from at least 7 oocytes per treatment. P values were calculated using ANOVA in conjunction with Tukey's multiple comparisons test. PfCRT CQRexpressing oocytes from the same batch, and on the same day of the electrophysiological measurements, accumulated [ 3 H]CQ significantly above levels in PfCRT CQS -expressing and non-injected oocytes at pH 6.0 (data not shown). Table S5 . Effects of different antimalarial drugs, amino acids, peptides, and organic cations on the uptake of [ 3 H]CQ into oocytes expressing PfCRT CQR -or PfCRT CQS . The majority of the 43 compounds tested had no effect. However, several peptides were found to cause a pronounced inhibition of CQ transport via PfCRT CQR . While three of the inhibitory peptides correspond to those thought to be generated from the parasite's digestion of human haemoglobin (43), a further five haemoglobin-derived peptides did not inhibit PfCRT CQR , consistent with the mutant transporter recognizing compounds with specific structural features, rather than recognizing haemoglobin-peptides per se (see table  S6 ). The concentration of the test-compound in the extracellular medium is indicated in parentheses. Stock solutions of the following compounds were made in DMSO (final concentration of DMSO either 0.17% (drugs) or 0.33% (peptides) v/v): quinine, quinidine, cinchonine, cinchonidine, amodiaquine, isoquine, mefloquine, artemisin, and peptides of three or more residues in length. Piperaquine was dissolved in 0.5% lactic acid (w/v) (final concentration of lactic acid 0.003% w/v). Stock solutions of the remaining compounds (CQ, primaquine, amantadine, amino acids, dipeptides, cephalexin, and organic cations) were made in the reaction buffer (see Methods). There was no significant difference in [ 3 H]CQ uptake between solvent controls and solvent-free controls (data not shown). Uptake is shown as mean ± s.e.m. from 3-4 separate experiments, within which measurements were made from 10 oocytes per treatment. Amino acids are indicated by the standard single-letter code. Asterisks indicate significant difference (P < 0.005; paired ttest) between the level of uptake measured in the presence and absence of the testcompound.
